Post-authorization trials and monitoring programs are conducted after the issuance of the marketing authorization and market appearance of the medicinal product. These trials are designed to collect additional information on side effects, safety, as well as long-term risks and benefits of the drug when it is widely used.
Qualification and experience of our company will help you to conduct post-authorization trials and organize monitoring programs at the highest level in accordance with the stated goal and objectives, while obtaining the maximum information about the properties of your drug. These data will be of benefit to patients in the future, thereby increasing interest in this drug.
75-2 Respublikanskaya St., Yaroslavl 150000, Russia
+7 4852 59-47-71, 59-47-79, +7 910 822-22-20